CA3134049A1 - Capsules and capsule coatings for gastric residence dosage forms - Google Patents
Capsules and capsule coatings for gastric residence dosage forms Download PDFInfo
- Publication number
- CA3134049A1 CA3134049A1 CA3134049A CA3134049A CA3134049A1 CA 3134049 A1 CA3134049 A1 CA 3134049A1 CA 3134049 A CA3134049 A CA 3134049A CA 3134049 A CA3134049 A CA 3134049A CA 3134049 A1 CA3134049 A1 CA 3134049A1
- Authority
- CA
- Canada
- Prior art keywords
- gastric residence
- dosage form
- coating
- capsule
- less
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4891—Coated capsules; Multilayered drug free capsule shells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
- A61J3/005—Coating of tablets or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
- A61J3/07—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of capsules or similar small containers for oral use
- A61J3/071—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of capsules or similar small containers for oral use into the form of telescopically engaged two-piece capsules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/485—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962821352P | 2019-03-20 | 2019-03-20 | |
| US62/821,352 | 2019-03-20 | ||
| PCT/US2020/023704 WO2020191229A1 (en) | 2019-03-20 | 2020-03-19 | Capsules and capsule coatings for gastric residence dosage forms |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA3134049A1 true CA3134049A1 (en) | 2020-09-24 |
Family
ID=72519175
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA3134049A Pending CA3134049A1 (en) | 2019-03-20 | 2020-03-19 | Capsules and capsule coatings for gastric residence dosage forms |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US12447130B2 (cg-RX-API-DMAC10.html) |
| EP (1) | EP3941445A4 (cg-RX-API-DMAC10.html) |
| JP (2) | JP2022525926A (cg-RX-API-DMAC10.html) |
| CN (2) | CN113966216A (cg-RX-API-DMAC10.html) |
| AU (1) | AU2020240108B2 (cg-RX-API-DMAC10.html) |
| BR (1) | BR112021018496A2 (cg-RX-API-DMAC10.html) |
| CA (1) | CA3134049A1 (cg-RX-API-DMAC10.html) |
| IL (1) | IL286512B2 (cg-RX-API-DMAC10.html) |
| MX (2) | MX429213B (cg-RX-API-DMAC10.html) |
| WO (1) | WO2020191229A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2020117855A1 (en) | 2018-12-03 | 2020-06-11 | Lyndra, Inc. | Stomach simulating device |
| IL286512B2 (en) | 2019-03-20 | 2026-03-01 | Lyndra Therapeutics Inc | Capsules and capsule coatings for stomach-retaining dosage forms |
| CN113840596A (zh) | 2019-03-20 | 2021-12-24 | 林德拉治疗公司 | 用于胃滞留剂型的衣层 |
| CN116234540A (zh) | 2020-07-29 | 2023-06-06 | 赛康特集团有限责任公司 | 具有包括交联聚(癸二酸甘油酯)的结构的形状引导控释和滞留 |
| EP4565274A2 (en) * | 2022-08-03 | 2025-06-11 | Lyndra Therapeutics, Inc. | Metal cores for gastric residence systems |
Family Cites Families (49)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9706149D0 (en) | 1997-03-25 | 1997-05-14 | Scherer Corp R P | Comestible capsules having flavoured coatings |
| US20050064027A1 (en) * | 2001-12-15 | 2005-03-24 | Spherics, Inc. | Bioadhesive drug delivery system with enhanced gastric retention |
| PT1578350E (pt) | 2002-03-26 | 2009-08-27 | Euro Celtique Sa | Composições revestidas com geles de libertação constante |
| IL166183A0 (en) * | 2005-01-06 | 2006-01-15 | Yissum Res Dev Co | Novel diagnostic and imaging techniques of the gi tract |
| CN101232868A (zh) | 2005-04-19 | 2008-07-30 | 阿尔扎公司 | 曲马多和加巴喷丁的控释递药剂型 |
| EP1901721A1 (en) * | 2005-06-23 | 2008-03-26 | Spherics, Inc. | Delayed release or extended-delayed release dosage forms of pramipexole |
| JP4948828B2 (ja) | 2005-11-28 | 2012-06-06 | 森下仁丹株式会社 | 胃内浮遊滞留シームレスカプセルとその製造方法 |
| JP2009523175A (ja) | 2006-01-10 | 2009-06-18 | パイペックス,インコーポレイテッド | 目標とされる安定な銅状態を達成及び維持して銅関連中枢神経系疾患を予防及び治療するための医薬組成物及び方法 |
| DK2997953T3 (en) | 2006-01-18 | 2019-04-15 | Intec Pharma Ltd | ADMINISTRATION ORAL ADMINISTRATION |
| WO2007093999A1 (en) | 2006-02-15 | 2007-08-23 | Intec Pharma Ltd. | A gastro-retentive system for the delivery of macromolecules |
| KR20110042366A (ko) | 2008-08-18 | 2011-04-26 | 팀 아카데미 오브 파마슈티컬 사이언스 | 위장체류 약물 전달 시스템, 제작 방법 및 그것들의 사용 |
| US8006033B2 (en) | 2008-09-09 | 2011-08-23 | Intel Corporation | Systems, methods, and apparatuses for in-band data mask bit transmission |
| WO2010064139A2 (en) | 2008-12-04 | 2010-06-10 | Intec Pharma Ltd. | Zaleplon gastroretentive drug delivery system |
| US20100286628A1 (en) * | 2009-05-07 | 2010-11-11 | Rainbow Medical Ltd | Gastric anchor |
| US8414559B2 (en) * | 2009-05-07 | 2013-04-09 | Rainbow Medical Ltd. | Gastroretentive duodenal pill |
| WO2011048494A2 (en) * | 2009-10-19 | 2011-04-28 | Intec Pharma Ltd. | Novel gastroretentive dosage forms of poorly soluble drugs |
| CN103402502A (zh) | 2011-02-14 | 2013-11-20 | 宝洁公司 | 包衣中包含蜂蜜的膜包衣固体剂型 |
| EP3459570B1 (en) | 2012-08-29 | 2021-03-10 | Cardiac Pacemakers, Inc. | Enhanced low friction coating for medical leads and methods of making |
| US10485758B2 (en) | 2014-06-02 | 2019-11-26 | Clexio Biosciences Ltd. | Expandable gastroretentive dosage form |
| US20170266112A1 (en) | 2014-06-11 | 2017-09-21 | Massachusetts Institute Of Technology | Residence structures and related methods |
| MX2016016406A (es) | 2014-06-11 | 2017-10-12 | Massachusetts Inst Technology | Estructuras de permanencia, y métodos relacionados. |
| WO2015195989A1 (en) | 2014-06-20 | 2015-12-23 | Banner Life Sciences Llc | Enteric soft capsule compositions |
| WO2016178971A1 (en) | 2015-05-01 | 2016-11-10 | Massachusetts Institute Of Technology | Triggerable shape memory induction devices |
| EA201890068A1 (ru) | 2015-06-17 | 2018-09-28 | Байоджен Ма Инк. | Частицы диметилфумарата и фармацевтические композиции на их основе |
| JPWO2017022248A1 (ja) * | 2015-08-04 | 2018-05-24 | 富士カプセル株式会社 | 腸溶性カプセル |
| AU2016342374B2 (en) | 2015-10-23 | 2022-08-04 | Nortiva Bio, Inc. | Gastric residence systems for sustained release of therapeutic agents and methods of use thereof |
| KR102796240B1 (ko) | 2015-12-08 | 2025-04-16 | 린드라 테라퓨틱스 인코퍼레이티드 | 위 체류 시스템을 위한 기하 구성형태 |
| US12109305B2 (en) | 2016-05-27 | 2024-10-08 | Lyndra Therapeutics, Inc. | Materials architecture for gastric residence systems |
| EP3518902A4 (en) * | 2016-09-30 | 2020-07-08 | Lyndra, Inc. | GASTRIC RESIDENCE SYSTEMS FOR LONG-TERM ADMINISTRATION OF ADAMANTANE CLASS MEDICINES |
| ES2966736T3 (es) * | 2016-12-02 | 2024-04-24 | Clexio Biosciences Ltd | Sistema de residencia gástrica |
| TWI811221B (zh) | 2017-06-09 | 2023-08-11 | 美商萊恩卓治療公司 | 具有釋放速率調節膜之胃的滯留系統 |
| JP7288435B2 (ja) | 2017-09-20 | 2023-06-07 | リンドラ セラピューティクス, インコーポレイティド | 胃内滞留システムのカプセル封入 |
| JP7394775B2 (ja) * | 2017-11-28 | 2023-12-08 | マサチューセッツ インスティテュート オブ テクノロジー | 胃滞在電子機器 |
| CA3118056A1 (en) | 2018-08-15 | 2020-02-20 | Lyndra, Inc. | Systems for enteric delivery of therapeutic agents |
| WO2020117855A1 (en) | 2018-12-03 | 2020-06-11 | Lyndra, Inc. | Stomach simulating device |
| IL286512B2 (en) | 2019-03-20 | 2026-03-01 | Lyndra Therapeutics Inc | Capsules and capsule coatings for stomach-retaining dosage forms |
| CN113840596A (zh) | 2019-03-20 | 2021-12-24 | 林德拉治疗公司 | 用于胃滞留剂型的衣层 |
| CA3160665A1 (en) | 2019-11-08 | 2021-05-14 | Lyndra Therapeutics, Inc. | Gastric residence systems for administration of active agents |
| IL292848A (en) | 2019-11-08 | 2022-07-01 | Lyndra Therapeutics Inc | Polymeric links for the gastric retention system |
| WO2021092486A1 (en) | 2019-11-08 | 2021-05-14 | Lyndra, Inc. | Formulations for release-rate modulating films for gastric residence systems |
| EP4054538A4 (en) | 2019-11-08 | 2024-02-07 | Lyndra Therapeutics, Inc. | STOMACH RESIDENCE SYSTEMS WITH A FILAMENT FOR IMPROVED STOMACH RESIDENCE |
| WO2021092484A1 (en) | 2019-11-08 | 2021-05-14 | Lyndra, Inc. | Gastric residence systems having arms with controlled stiffness for improved gastric residence |
| JP2024503485A (ja) | 2021-01-19 | 2024-01-25 | リンドラ セラピューティクス, インコーポレイティド | リスペリドンを投与するための胃内滞留システム |
| EP4333823A4 (en) | 2021-05-05 | 2025-04-09 | Lyndra Therapeutics, Inc. | Indwelling gastric sytems containing buprenorphine and naloxone |
| AU2022270208A1 (en) | 2021-05-05 | 2023-12-07 | Lyndra Therapeutics, Inc. | Gastric residence systems comprising methadone |
| IL314378A (en) | 2022-01-19 | 2024-09-01 | Lyndra Therapeutics Inc | Dosage forms for gastric preservation |
| EP4565274A2 (en) | 2022-08-03 | 2025-06-11 | Lyndra Therapeutics, Inc. | Metal cores for gastric residence systems |
| JP2025531626A (ja) | 2022-09-30 | 2025-09-22 | リンドラ セラピューティクス, インコーポレイティド | 胃内滞留システムを用いたリスペリドンの投与レジメン |
| WO2024249946A2 (en) | 2023-06-02 | 2024-12-05 | Lyndra Therapeutics, Inc. | Manufacturing methods for gastric residence systems |
-
2020
- 2020-03-19 IL IL286512A patent/IL286512B2/en unknown
- 2020-03-19 CA CA3134049A patent/CA3134049A1/en active Pending
- 2020-03-19 EP EP20774505.0A patent/EP3941445A4/en active Pending
- 2020-03-19 CN CN202080034334.4A patent/CN113966216A/zh active Pending
- 2020-03-19 US US17/593,436 patent/US12447130B2/en active Active
- 2020-03-19 BR BR112021018496A patent/BR112021018496A2/pt unknown
- 2020-03-19 JP JP2021556484A patent/JP2022525926A/ja active Pending
- 2020-03-19 AU AU2020240108A patent/AU2020240108B2/en active Active
- 2020-03-19 CN CN202411107403.6A patent/CN119033720A/zh active Pending
- 2020-03-19 WO PCT/US2020/023704 patent/WO2020191229A1/en not_active Ceased
- 2020-03-19 MX MX2021011314A patent/MX429213B/es unknown
-
2021
- 2021-09-17 MX MX2025012985A patent/MX2025012985A/es unknown
-
2025
- 2025-01-16 JP JP2025005892A patent/JP2025066761A/ja active Pending
- 2025-07-08 US US19/262,609 patent/US20250332111A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP3941445A1 (en) | 2022-01-26 |
| US20250332111A1 (en) | 2025-10-30 |
| MX429213B (es) | 2025-11-13 |
| IL286512B2 (en) | 2026-03-01 |
| US20220160642A1 (en) | 2022-05-26 |
| MX2025012985A (es) | 2025-12-01 |
| AU2020240108B2 (en) | 2025-12-04 |
| JP2022525926A (ja) | 2022-05-20 |
| IL286512A (en) | 2021-10-31 |
| EP3941445A4 (en) | 2023-08-02 |
| MX2021011314A (es) | 2021-12-10 |
| US12447130B2 (en) | 2025-10-21 |
| IL286512B1 (en) | 2025-11-01 |
| AU2020240108A1 (en) | 2021-11-11 |
| BR112021018496A2 (pt) | 2021-11-30 |
| JP2025066761A (ja) | 2025-04-23 |
| CN119033720A (zh) | 2024-11-29 |
| WO2020191229A1 (en) | 2020-09-24 |
| CN113966216A (zh) | 2022-01-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20250332111A1 (en) | Capsules and capsule coatings for gastric residence dosage forms | |
| US12582608B2 (en) | Coatings for gastric residence dosage forms | |
| JP2022525926A5 (cg-RX-API-DMAC10.html) | ||
| RU2428176C2 (ru) | Системы доставки лекарственного средства, содержащие слабоосновные лекарственные средства и органические кислоты | |
| ES2728850T3 (es) | Dispersiones acuosas de acetato acetato succinato de hidroxipropilmetilcelulosa (HPMCAS) | |
| US9579293B2 (en) | Timed, pulsatile release systems | |
| ES2260253T3 (es) | Composicion farmaceutica oral de liberacion controlada y absorcion prolongada. | |
| JP2022525482A5 (cg-RX-API-DMAC10.html) | ||
| EP0470047A1 (en) | Sustained release formulations | |
| JP2004513913A (ja) | 持続放出性抗高血糖薬マイクロカプセルに基づく薬剤およびその調製方法 | |
| BRPI0618175A2 (pt) | tecnologia para revestimento de múltiplas camadas para o mascaramento de sabor | |
| CN101686947A (zh) | 度洛西汀制剂 | |
| AU2020225818A1 (en) | Preserving functionally-coated API particles produced by solventless mixing processes in aqueous suspension | |
| HK40066247A (en) | Coatings for gastric residence dosage forms | |
| HK40066247B (en) | Coatings for gastric residence dosage forms | |
| CN118829419A (zh) | 含有大环内酯类免疫抑制剂的经粘膜治疗系统 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |
Effective date: 20220928 |
|
| P11 | Amendment of application requested |
Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-P100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: AMENDMENT RECEIVED - RESPONSE TO EXAMINER'S REQUISITION Effective date: 20240726 |
|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: A-2-2-W10-W00-W111 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CORRESPONDENT DETERMINED COMPLIANT Effective date: 20241007 |
|
| MFA | Maintenance fee for application paid |
Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 5TH ANNIV.) - STANDARD Year of fee payment: 5 |
|
| U00 | Fee paid |
Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED Effective date: 20241220 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT DETERMINED COMPLIANT Effective date: 20241220 Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL Effective date: 20241220 |
|
| P11 | Amendment of application requested |
Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-P102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: AMENDMENT DETERMINED COMPLIANT Effective date: 20250212 |
|
| P13 | Application amended |
Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P13-X000 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: APPLICATION AMENDED Effective date: 20250212 |
|
| D15 | Examination report completed |
Free format text: ST27 STATUS EVENT CODE: A-2-2-D10-D15-D126 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: EXAMINER'S REPORT Effective date: 20250707 |
|
| P11 | Amendment of application requested |
Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-P100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: AMENDMENT RECEIVED - RESPONSE TO EXAMINER'S REQUISITION Effective date: 20251106 |
|
| MFA | Maintenance fee for application paid |
Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 6TH ANNIV.) - STANDARD Year of fee payment: 6 |
|
| U00 | Fee paid |
Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED Effective date: 20251216 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL Effective date: 20251216 |
|
| P11 | Amendment of application requested |
Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-P102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: AMENDMENT DETERMINED COMPLIANT Effective date: 20251231 |
|
| P13 | Application amended |
Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P13-X000 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: APPLICATION AMENDED Effective date: 20251231 |
|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: A-2-2-W10-W00-W111 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CORRESPONDENT DETERMINED COMPLIANT Effective date: 20251231 |
|
| R11 | Change to the name of applicant or owner or transfer of ownership requested |
Free format text: ST27 STATUS EVENT CODE: A-2-2-R10-R11-R127 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: TRANSFER RECORDAL REQUEST OR RESPONSE Effective date: 20260122 Free format text: ST27 STATUS EVENT CODE: A-2-2-R10-R11-R103 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CHANGE OF NAME REQUEST RECEIVED Effective date: 20260122 |
|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: A-2-2-W10-W00-W111 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CORRESPONDENT DETERMINED COMPLIANT Effective date: 20260127 |
|
| R14 | Transfer of ownership recorded |
Free format text: ST27 STATUS EVENT CODE: A-2-2-R10-R14-R129 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: TRANSFER REQUIREMENTS DETERMINED COMPLIANT Effective date: 20260128 |
|
| R13 | Change to the name of applicant or owner recorded |
Free format text: ST27 STATUS EVENT CODE: A-2-2-R10-R13-R104 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CHANGE OF NAME REQUIREMENTS DETERMINED COMPLIANT Effective date: 20260223 |
|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: A-2-2-W10-W00-W111 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CORRESPONDENT DETERMINED COMPLIANT Effective date: 20260223 |
|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: A-2-2-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT Effective date: 20260514 |
|
| D00 | Search and/or examination requested or commenced |
Free format text: ST27 STATUS EVENT CODE: A-2-2-D10-D00-D149 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: EXAMINER'S INTERVIEW Effective date: 20260720 |
|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: A-2-2-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT Effective date: 20260729 |
|
| P11 | Amendment of application requested |
Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-P101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: AMENDMENT RECEIVED - VOLUNTARY AMENDMENT Effective date: 20260804 |